CHARLES SCHWAB INVESTMENT MANAGEMENT INC - MARKER THERAPEUTICS INC ownership

MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 75 filers reported holding MARKER THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of MARKER THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$26,000
-42.2%
26,5620.0%0.00%
Q3 2021$45,000
-40.0%
26,5620.0%0.00%
Q2 2021$75,000
-54.8%
26,562
-64.0%
0.00%
Q1 2021$166,000
+55.1%
73,7130.0%0.00%
Q4 2020$107,000
-3.6%
73,7130.0%0.00%
Q3 2020$111,000
-27.5%
73,7130.0%0.00%
Q2 2020$153,000
+24.4%
73,713
+14.1%
0.00%
Q1 2020$123,000
-34.2%
64,5930.0%0.00%
Q4 2019$187,000
-43.5%
64,5930.0%0.00%
Q3 2019$331,000
-35.4%
64,5930.0%0.00%
Q2 2019$512,00064,5930.00%
Other shareholders
MARKER THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Aisling Capital Management LP 3,142,857$2,986,0001.05%
ACT CAPITAL MANAGEMENT, LLC 354,400$337,0000.24%
NEA Management Company, LLC 10,714,285$10,179,0000.21%
Long Focus Capital Management, LLC 1,233,257$1,172,0000.16%
Mandatum Life Insurance Co Ltd 99,000$94,0000.02%
MATRIX ASSET ADVISORS INC/NY 150,000$143,0000.02%
AR ASSET MANAGEMENT INC 71,500$68,0000.02%
KENNEDY CAPITAL MANAGEMENT LLC 590,118$561,0000.01%
WealthTrust Axiom LLC 22,700$21,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 324,216$308,0000.01%
View complete list of MARKER THERAPEUTICS INC shareholders